From: Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
Variable | univariable analysis | multivariable analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | |
UICC stage at diagnosis (<IV vs. IV) | 0.63 | 0.355 - 1.12 | 0.11 | |||
ECM | 1.59 | 0.69-3.69 | 0.28 | |||
Synchronous BM | 1.56 | 0.49-5.03 | 0.46 | |||
Gender (m vs. f) | 1.18 | 0.73 - 1.91 | 0.5 | |||
highest BED10 (< vs. > = median) | 1.14 | 0.67-1.92 | 0.63 | |||
Age (< vs. > = median) | 1.05 | 0.67 - 1.69 | 0.83 | |||
Cumulative BM volume (< vs. > = median) | 2.486 | 1.5 - 4.13 | < 0.001 (*) | 1 | 0.94 - 1.06 | 0.87 |
KPS (<90% vs. > = 90%) | 2.16 | 1.3 - 3.59 | 0.003 (*) | 3.99 | 1.78 - 8.96 | 0.001 (*) |
Single vs. multiple lesions | 1.68 | 1.04 - 2.72 | 0.034 (*) | 3.55 | 1.71 - 7.35 | 0.001 (*) |
Histology (NM vs. other) | 1.9 | 1.02 - 3.52 | 0.043 (*) | 2.26 | 1.12 - 4.54 | 0.022 (*) |
Interval PT diagnosis to SRT (< vs. > = median) | 0.66 | 0.41-1.06 | 0.086 (+) | 0.79 | 0.38 - 1.66 | 0.54 |